Literature DB >> 22801853

Exacerbation of Susac syndrome retinopathy by interferon Beta-1a.

Philip W Laird, Nancy J Newman, Steven Yeh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22801853      PMCID： PMC3809003          DOI： 10.1001/archophthalmol.2011.1841

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  5 in total

1.  Susac's Syndrome--update.

Authors:  Robert Rennebohm; John O Susac; Robert A Egan; Robert B Daroff
Journal:  J Neurol Sci       Date:  2010-09-19       Impact factor: 3.181

Review 2.  Susac syndrome.

Authors:  T Papo; V Biousse; P Lehoang; C Fardeau; N N'Guyen; D L Huong; O Aumaitre; M G Bousser; P Godeau; J C Piette
Journal:  Medicine (Baltimore)       Date:  1998-01       Impact factor: 1.889

3.  [Retinopathy secondary to treatment with Interferon beta-1a in a patient with multiple sclerosis].

Authors:  J Mallada-Frechín; I Abellán-Miralles; M L Alfaro-Beltra; V Medrano; M B Muñoz-Gil; S Fernández-Izquierdo; L Piqueras-Rodríguez
Journal:  Rev Neurol       Date:  2005 Apr 16-30       Impact factor: 0.870

4.  Idiopathic recurrent branch retinal arterial occlusion.

Authors:  J D Gass; J Tiedeman; M A Thomas
Journal:  Ophthalmology       Date:  1986-09       Impact factor: 12.079

5.  Cotton wool spots associated with interferon beta-1 alpha therapy.

Authors:  Reid Longmuir; Andrew G Lee; Jacinthe Rouleau
Journal:  Semin Ophthalmol       Date:  2007 Jan-Mar       Impact factor: 1.975
  5 in total
  7 in total

1.  Treatment of Susac Syndrome.

Authors:  Ivana Vodopivec; Sashank Prasad
Journal:  Curr Treat Options Neurol       Date:  2016-01       Impact factor: 3.598

Review 2.  Distinguishing Susac's syndrome from multiple sclerosis.

Authors:  Katherine A Buzzard; Stephen W Reddel; Con Yiannikas; D Sean Riminton; Michael H Barnett; Todd A Hardy
Journal:  J Neurol       Date:  2014-12-30       Impact factor: 4.849

Review 3.  Characteristics of Susac syndrome: a review of all reported cases.

Authors:  Jan Dörr; Sarah Krautwald; Brigitte Wildemann; Sven Jarius; Marius Ringelstein; Thomas Duning; Orhan Aktas; Erich Bernd Ringelstein; Friedemann Paul; Ilka Kleffner
Journal:  Nat Rev Neurol       Date:  2013-04-30       Impact factor: 42.937

Review 4.  Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature.

Authors:  Lorenzo Gaetani; Paola S Menduno; Francesco Cometa; Maria Di Gregorio; Paola Sarchielli; Carlo Cagini; Paolo Calabresi; Massimiliano Di Filippo
Journal:  J Neurol       Date:  2015-08-21       Impact factor: 4.849

5.  [Susac syndrome-interdisciplinary tracking of the chameleon: two different case reports].

Authors:  D Schelenz; I Kleffner; N Tsiampalis; H Burkhard Dick; J Rehrmann
Journal:  Ophthalmologe       Date:  2020-04       Impact factor: 1.059

6.  Susac syndrome misdiagnosed as multiple sclerosis with exacerbation by interferon beta therapy.

Authors:  Hussein Algahtani; Bader Shirah; Muhammad Amin; Eyad Altarazi; Hashem Almarzouki
Journal:  Neuroradiol J       Date:  2017-06-23

7.  Diagnosis, differential diagnosis and misdiagnosis of Susac syndrome.

Authors:  James D Triplett; Jessica Qiu; Billy O'Brien; Sumana Gopinath; Benjamin Trewin; Penelope J Spring; Mohamed Shaffi; Jerome Ip; Fiona Chan; Luke Chen; Ian Wilson; Claire Muller; Heidi N Beadnall; Mike Boggild; Anneke Van der Walt; Richard Roxburgh; Nabil Seery; Tomas Kalincik; Michael H Barnett; John D E Parratt; Stephen W Reddel; Benjamin Tsang; Todd A Hardy
Journal:  Eur J Neurol       Date:  2022-03-25       Impact factor: 6.288
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.